Skip to main content
. 2024 Jul 25;14(1):124. doi: 10.1038/s41408-024-01107-6

Table 5.

Considerations for discontinuing IgG-RT.

• Consider pausing IgG-RT 9–12 months after discontinuation of B cell-depleting therapy
• Monitor for endogenous recovery of CD19+ B cells, CD20+ B cells, IgG, IgM, and IgA
• Able to maintain IgG ≥400 mg/dL for three consecutive months off IgG-RT without evidence of recurrent bacterial infections
• Protective vaccine responses checked 3–4 months after IgG-RT discontinuation